Insider Trading Alert - ATVI, MDVN And NSP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 12, 2015, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $4,322,819.24.

Highlighted Stocks Traded by Insiders:

Activision Blizzard (ATVI) - FREE Research Report

Hodous Brian, who is Chief Customer Officer at Activision Blizzard, sold 43,942 shares at $24.57 on May 12, 2015. Following this transaction, the Chief Customer Officer owned 152,119 shares meaning that the stake was reduced by 22.41% with the 43,942-share transaction.

The shares most recently traded at $24.73, up $0.16, or 0.64% since the insider transaction. Historical insider transactions for Activision Blizzard go as follows:

  • 4-Week # shares sold: 12,133
  • 12-Week # shares sold: 12,133
  • 24-Week # shares sold: 12,133

The average volume for Activision Blizzard has been 5.0 million shares per day over the past 30 days. Activision Blizzard has a market cap of $17.9 billion and is part of the technology sector and computer software & services industry. Shares are up 22.28% year-to-date as of the close of trading on Tuesday.

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games worldwide. The stock currently has a dividend yield of 0.93%. The company has a P/E ratio of 19.6. Currently, there are 18 analysts who rate Activision Blizzard a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATVI - FREE

TheStreet Quant Ratings rates Activision Blizzard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and attractive valuation levels. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Activision Blizzard Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medivation (MDVN) - FREE Research Report

Bierly Rick, who is Chief Financial Officer at Medivation, sold 385 shares at $125.00 on May 12, 2015. Following this transaction, the Chief Financial Officer owned 15,841 shares meaning that the stake was reduced by 2.37% with the 385-share transaction.

The shares most recently traded at $122.94, down $2.06, or 1.68% since the insider transaction. Historical insider transactions for Medivation go as follows:

  • 4-Week # shares sold: 3,785
  • 12-Week # shares sold: 129,614
  • 24-Week # shares sold: 241,324

The average volume for Medivation has been 1.0 million shares per day over the past 30 days. Medivation has a market cap of $9.7 billion and is part of the health care sector and drugs industry. Shares are up 23.6% year-to-date as of the close of trading on Tuesday.

Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients. The company has a P/E ratio of 33.0. Currently, there are 11 analysts who rate Medivation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDVN - FREE

TheStreet Quant Ratings rates Medivation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, notable return on equity, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Medivation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Insperity (NSP) - FREE Research Report

Fields Jack M Jr, who is Director at Insperity, sold 176 shares at $53.41 on May 12, 2015. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 176-share transaction.

Sharp Douglas S, who is SVP Finance, CFO & Treasurer at Insperity, sold 4,245 shares at $53.06 on May 12, 2015. Following this transaction, the SVP Finance, CFO & Treasurer owned 31,624 shares meaning that the stake was reduced by 11.83% with the 4,245-share transaction.

The shares most recently traded at $52.45, down $0.61, or 1.16% since the insider transaction. Historical insider transactions for Insperity go as follows:

  • 4-Week # shares sold: 44,667
  • 12-Week # shares sold: 49,667
  • 24-Week # shares sold: 110,921

The average volume for Insperity has been 258,900 shares per day over the past 30 days. Insperity has a market cap of $1.4 billion and is part of the services sector and diversified services industry. Shares are up 57.33% year-to-date as of the close of trading on Tuesday.

Insperity, Inc. provides an array of human resources (HR) and business solutions to enhance business performance for small and medium-sized businesses in the United States. The stock currently has a dividend yield of 1.43%. The company has a P/E ratio of 43.7. Currently, there are 2 analysts who rate Insperity a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NSP - FREE

TheStreet Quant Ratings rates Insperity as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Insperity Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices